TDO2 and renal cell carcinoma: Knockdown of anoikis-related protein Tryptophan 2,3-dioxygenase (TDO2) inhibits the proliferation and invasion of RCC cells and may be a promising marker for RCC targeted therapy (Pham et al., 2021).